Helminths as governors of inflammatory bowel disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. Natural Product-based Therapies for Inflammatory Bowel Disease: Targeting Key Signaling Pathways.Mini reviews in medicinal chemistry · 2025
   Review
2. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments.Nutrients · 2023
   Review
3. Effects of helminths on the human immune response and the microbiome.Mucosal immunology · 2022
   Review
4. Frontiers in cell and developmental biology · 2021
   Article
5. Deciphering Biological Processes at the Tick-Host Interface Opens New Strategies for Treatment of Human Diseases.Frontiers in physiology · 2019
   Review
6. SXP-RAL Family Filarial Protein, rWbL2, Prevents Development of DSS-Induced Acute Ulcerative Colitis.Indian journal of clinical biochemistry : IJCB · 2018
   Article
7. Larval Echinococcus multilocularis infection reduces dextran sulphate sodium-induced colitis in mice by attenuating T helper type 1/type 17-mediated immune reactions.Immunology · 2018
   Article
8. Zoonotic intestinal helminths interact with the canine immune system by modulating T cell responses and preventing dendritic cell maturation.Scientific reports · 2017
   Article
9. Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel.Gut and liver · 2016
   Review
10. Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of mice.Parasites & vectors · 2016
    Article
11. Do We Need Worms to Promote Immune Health?Clinical reviews in allergy & immunology · 2015
    Review
12. The relationship between intestinal parasites and some immune-mediated intestinal conditions.Gastroenterology and hepatology from bed to bench · 2015
    Review
13. Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis.Journal of immunology (Baltimore, Md. : 1950) · 2013
    Article
14. Where are we on worms?Current opinion in gastroenterology · 2012
    Review
15. Helminth-host immunological interactions: prevention and control of immune-mediated diseases.Annals of the New York Academy of Sciences · 2012
    Review
16. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.Multiple sclerosis (Houndmills, Basingstoke, England) · 2011
    Article
17. Regulatory T cells in infection.Advances in immunology · 2011
    Review
18. Advances in the pathogenesis and treatment of IBD.Clinical immunology (Orlando, Fla.) · 2009
    Review
19. Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases.Mediators of inflammation · 2009
    Review

Corrections and comments

• Comment on
  Trichuris suis therapy in Crohn's disease.2005

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as